Skip to main content

Advertisement

Table 1 Cases and histopathology

From: Mitochondrial DNA sequencing demonstrates clonality of peritoneal implants of borderline ovarian tumors

Patients Age at diagnosis Surgery Histology Staging (FIGO 2014) Implant type Implant localization DFS OS
B1 35 FS Serous BOT IIB Non invasive Pelvic peritoneum 48 74
B2 44 CS Serous BOT IIC3 Non invasive Pelvic peritoneum 34 34
B3 30 FS Serous BOT with intraepithelial carcinoma IIIA Non invasive Pelvic peritoneum and omentum 31 31
B4 81 CS Serous BOT IIB Non invasive Pelvic peritoneum 120 120
B5 23 FS Serous BOT with intraepithelial carcinoma IIC3 Invasive Pelvic peritoneum 30 67
B6 32 FS Serous BOT IIC3 Non invasive Pelvic peritoneum 7 68
B7 34 FS Serous BOT IIIA Non invasive Pelvic peritoneum, pararectal peritoneum 13 128
B8 63 CS Serous BOT IIIA Non invasive Pelvic peritoneum, omentum and right diaphragmatic peritoneum 16 16
  1. Age, surgery, histology and FIGO stage of borderline ovarian tumors, implants type and localization, months from treatment until first relapse and months from diagnosis to last follow up are shown
  2. Abbreviations: FS Fertility Sparing treatment, CS Complete Staging, BOT Borderline Ovarian Tumor, DFS Disease Free Survival, OS Overall Survival